Molecular pathology in sarcomas

Clinical and Translational Oncology

Volumn 9, Issue 3, 2007, Pages 130-144

  Alava E ^a  

^a CSIC   (Spain)

Author keywords

Ewing tumours; GIST; Li Fraumeni syndrome; Sarcomas

Indexed keywords

DOXORUBICIN; IMATINIB; STEM CELL FACTOR RECEPTOR; SUNITINIB; WT1 PROTEIN; ONCOPROTEIN; TUMOR MARKER; TUMOR PROTEIN;

CANCER INCIDENCE; CHROMOSOME TRANSLOCATION; CLINICAL TRIAL; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; EWING SARCOMA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FAMILIAL CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL STROMAL TUMOR; GENE AMPLIFICATION; GENE FUSION; GENE MUTATION; HEMANGIOPERICYTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MICROARRAY ANALYSIS; MINIMAL RESIDUAL DISEASE; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; MYOEPITHELIOMA; NONHUMAN; OSTEOSARCOMA; POINT MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SARCOMA; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; ADOLESCENT; ADULT; ANEUPLOIDY; CHEMISTRY; CHILD; CHROMOSOME ABERRATION; CLASSIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADOLESCENT; ADULT; ANEUPLOIDY; BASE SEQUENCE; CHILD; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; NEOPLASTIC SYNDROMES, HEREDITARY; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 34249946843     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0027-2     Document Type: Review

References (65)

1. Mackall CL, Meltzer PS, Helman LJ (2002) Focus on sarcomas. Cancer Cell 2:175-178
2. Collin F, Gelly-Marty M, Bui Nguyen Binh M, Coindre JM (2006) Soft tissue sarcomas: Current data in the field of pathology. Cancer Radiother 10:7-14
3. de Alava E, Navarro S, Segura DI, Peris-Bonet R (2004) Aspectos y recomendaciones sobre el funcionamiento de los bancos de tumores. Documento de consenso. http://ritsi.uv.es
4. Abramson DH, Ellsworth RM, Kitchin FD, Tung G (1984) Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology 91:1351-1355
5. Malkin D, Li FP, Strong LC et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238
6. King AA, Debaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93:388-392
7. Nishida T, Hirota S, Taniguchi M et al (1998) Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 19:323-324
8. Ladanyi M, Bridge JA (2000) Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol 31:532-538
9. Borden EC, Baker LH, Bell RS et al (2003) Soft tissue sarcomas of adults: State of the translational science. Clin Cancer Res 9:1941-1956
10. Huang HY, Illei PB, Zhao Z et al (2005) Ewing sarcomas with p53 mutation or p16/p14ARF ho- mozygous deletion: A highly lethal subset associated with poor chemoresponse. J Clin Oncol 23:548-558
11. Peter M, Gilbert E, Delattre O (2001) A multiplex real-time PCR assay for the detection of gene fusions observed in solid tumors. Lab Invest 81:905-912
12. Terry J, Barry TS, Horsman DE et al (2005) Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probe. Diagn Mol Pathol 14:77-82
13. Argani P, Lal P, Hutchinson B et al (2003) Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: A sensitive and specific immunohistochemical assay. Am J Surg Pathol 27:750-761
14. Hill DA, Pfeifer JD, Marley EF et al (2000) WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/ primitive neuroectodermal tumor. An immunohistochemical and molecular diagnostic study. Am J Clin Pathol 114:345-353
15. Cook JR, Dehner LP, Collins MH et al (2001) Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: A comparative immunohistochemical study. Am J Surg Pathol 25:1364-1371
16. Qian X, Jin L, Shearer BM et al (2005) Molecular diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor in formalin-fixed paraffinembedded tissues by RT-PCR and fluorescence in situ hybridization. Diagn Mol Pathol 14:23-28
17. Guillou L, Coindre J, Gallagher G et al (2001) Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: A reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives. Hum Pathol 32:105-112
18. Udayakumar AM, Sundareshan TS, Goud TM et al (2001) Cytogenetic characterization of Ewing tumors using fine needle aspiration samples. A 10-year experience and review of the literature. Cancer Genet Cytogenet 127:42-48
19. de Alava E, Kawai A, Healey JH et al (1998) EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16:1248-1255
20. de Alava E, Lozano MD, Sola I et al (1998) Molecular features in a biphenotypic small cell sarcoma with neuroectodermal and muscle differentiation. Hum Pathol 29:181-184
21. Bennicelli JL, Barr FG (2002) Chromosomal translocations and sarcomas. Curr Opin Oncol 14:412-419
22. de Alava E, Gerald WL (2000) Molecular biology of the Ewing's sarcoma/ primitive neuroectodermal tumor family. J Clin Oncol 18:204-213
23. Gerald WL, Ladanyi M, de Alava E et al (1998) Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol 16:3028-3036
24. Lee SB, Kolquist KA, Nichols K et al (1997) The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nat Genet 17:309-313
25. Palmer RE, Lee SB, Wong JC et al (2002) Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. Cancer Cell 2:497-505
26. Zucman J, Delattre O, Desmaze C et al (1993) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4:341-345
27. Hallor KH, Mertens F, Jin Y et al (2005) Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid f ibrous histiocytoma. Genes Chromosomes Cancer 44:97-102
28. Antonescu CR, Tschernyavsky SJ, Woodruff JM et al (2002) Molecular diagnosis of clear cell sarcoma: Detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn 4:44-52
29. Antonescu CR, Argani P, Erlandson RA et al (1998) Skeletal and extraskeletal myxoid chondrosarcoma: A comparative clinicopathologic, ultrastructural, and molecular study. Cancer 83:1504-1521
30. Subramanian S, West RB, Marinelli RJ et al (2005) The gene expression profile of extraskeletal myxoid chondrosarcoma. J Pathol 206: 433-444
31. Aman P, Panagopoulos I, Lassen C et al (1996) Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 37:1-8
32. Pŕez-Mancera PA, Sánchez-García I (2005) Understanding mesenchymal cancer: The liposarcoma- associated FUS-DDIT3 fusion gene as a model. Semin Cancer Biol 15:206-214
33. Barr FG, Galili N, Holick J et al (1993) Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet 3:113-117
34. Davis RJ, Barr FG (1997) Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A 94:8047-8051
35. Sorensen PH, Lynch JC, Qualman SJ et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: A report from the children's oncology group. J Clin Oncol 20:2672-2679
36. Kawai A, Woodruff J, Healey JH et al (1998) SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 338:153-160
37. Ladanyi M, Antonescu CR, Leung DH et al (2002) Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: A multiinstitutional retrospective study of 243 patients. Cancer Res 62:135-140
38. Oliveira AM, Fletcher CD (2004) Molecular prognostication for soft tissue sarcomas: Are we ready yet? J Clin Oncol 22:4031-4034
39. Knezevich SR, McFadden DE, Tao W et al (1998) A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184-187
40. Tognon C, Knezevich SR, Huntsman D et al (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2:367-376
41. McArthur GA, Demetri GD, van Oosterom A et al (2005) Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with Imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 23:866-873
42. Tuveson DA, Fletcher JA (2001) Signal transduction pathways in sarcoma as targets for therapeutic intervention. Curr Opin Oncol 13:249-255
43. Hu-Lieskovan S, Heidel JD, Bartlett DW et al (2005) Sequence-specific knockdown of EWSFLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res 65:8984-8992
44. Mendiola M, Carrillo J, Garcia E et al (2006) The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Int J Cancer 118: 1381-1389
45. Schleiermacher G, Peter M, Oberlin O et al (2003) Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor. J Clin Oncol 21:85-91
46. Kelly KM, Womer RB, Barr FG (1996) Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptasepolymerase chain reaction method. Cancer 78:1320-1327
47. de Alava E (2001) Transcripts, transcripts, everywhere. Adv Anat Pathol 8:264-272
48. Heinrich MC, Corless CL, Duensing A et al (2003) PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708-710
49. Kinoshita K, Hirota S, Isozaki K et al (2004) Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 202:80-85
50. Heinrich MC, Rubin BP, Longley BJ, Fletcher JA (2002) Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol 33:484-495
51. Heinrich MC, Corless CL, Demetri GD et al (2003) Kinase mutations and Imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21:4342-4349
52. Corless CL, Schroeder A, Griffith D et al (2005) PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 23:5357-5364
53. Singer S, Rubin BP, Lux ML et al (2002) Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 20:3898-3905
54. Thomas DG, Giordano TJ, Sanders D et al (2005) Expression of receptor tyrosine kinases epidermal growth factor receptor and HER- 2/neu in synovial sarcoma. Cancer 103:830-838
55. Mohr S, Leikauf GD, Keith G, Rihn BH (2002) Microarrays as cancer keys: an array of possibilities. J Clin Oncol 20:3165-3175
56. Nielsen TO, West RB, Linn SC et al (2002) Molecular characterisation of soft tissue tumours: A gene expression study. Lancet 359: 1301-1307
57. Segal NH, Pavlidis P, Noble WS et al (2003) Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol 21:1775-1781
58. Lee YF, John M, Falconer A et al (2004) A gene expression signature associated with metastatic outcome in human leiomyosarcomas. Cancer Res 64:7201-7204
59. Wachtel M, Dettling M, Koscielniak E et al (2004) Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 64:5539-5545
60. Baird K, Davis S, Antonescu CR et al (2005) Gene expression profiling of human sarcomas: Insights into sarcoma biology. Cancer Res 65:9226-9235
61. Ladanyi M, Chan WC, Triche TJ, Gerald WL (2001) Expression profiling of human tumors: The end of surgical pathology? J Mol Diagn 3: 92-97
62. van de Rijn M, Rubin BP (2002) Gene expression studies on soft tissue tumors. Am J Pathol 161:1531-1534
63. O'Sullivan M, Budhraja V, Sadovsky Y, Pfeifer JD (2005) Tumor heterogeneity affects the precision of microarray analysis. Diagn Mol Pathol 14:65-71
64. West RB, Corless CL, Chen X et al (2004) The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165:107-113
65. Blay P, Astudillo A, Buesa JM et al (2004) Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias. Clin Cancer Res 10:4089-4095